Bivalirudin - NDC Database


17 records found:

Sorted by NDC Code

Page of 1
0338-9572 Dec 21, 2017
Bivalirudin In 0.9% Sodium Chloride In 0.9% Sodium Chloride 250 mg/50ml Intravenous Injection by Baxter Healthcare Corporation
0338-9576 Dec 21, 2017
Bivalirudin In 0.9% Sodium Chloride In 0.9% Sodium Chloride 500 mg/100ml Intravenous Injection by Baxter Healthcare Corporation
0409-8300 Oct 05, 2015
Bivalirudin 250 mg Intravenous Injection, Powder, Lyophilized, for Solution by Hospira, Inc.
0781-3158 Jun 15, 2015
Bivalirudin 250 mg Intravenous Injection, Powder, Lyophilized, for Solution by Sandoz
0781-9158 Oct 23, 2015
Bivalirudin 250 mg Intravenous Injection, Powder, Lyophilized, for Solution by Sandoz
16729-275 Nov 07, 2018
Bivalirudin 250 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Accord Healthcare, Inc.
25021-405 Jan 15, 2019
Bivalirudin 250 mg Intravenous Injection, Powder, Lyophilized, for Solution by Sagent Pharmaceuticals
52958-034 Oct 28, 2019
Bivalirudin 250 mg Intravenous Injection, Powder, Lyophilized, for Solution by Hainan Shuangcheng Pharmaceuticals Co., Ltd.
55111-652 May 31, 2017
Bivalirudin 250 mg Intracavernous Injection by Dr. Reddy's Laboratories Limited
55150-210 Jul 27, 2018
Bivalirudin 250 mg Intravenous Injection, Powder, Lyophilized, for Solution by Auromedics Pharma LLC
60505-6101 Jul 17, 2017
Bivalirudin 250 mg Intravenous Injection, Powder, Lyophilized, for Solution by Apotex Corp
63323-562 Oct 30, 2017
Bivalirudin 250 mg Intravenous Injection, Powder, Lyophilized, for Solution by Fresenius Kabi USA, LLC
67457-256 Jun 05, 2018
Bivalirudin 250 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Mylan Institutional LLC
69097-601 Jul 16, 2018
Bivalirudin 250 mg Intravenous Injection by Cipla USA Inc.
70511-141 Aug 08, 2019
Bivalirudin 250 mg Intravenous Injection, Solution by Maia Pharmaceuticals, Inc.
70860-402 Nov 30, 2019
Bivalirudin 250 mg Intravenous Injection, Powder, Lyophilized, for Solution by Athenex Pharmaceutical Division, LLC.
70860-403 Mar 01, 2020
Bivalirudin Rtu 5 mg/ml Intravenous Injection, Solution by Athenex Pharmaceutical Division, LLC.

Notice: The MedsChat® NDC Database compiles publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.


Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 2 June 2020.

We are committed to your privacy.

Copyright © 2005-2020 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA